How to achieve micromonovision by iol implantation . Take reference from kanski & zia
Reading Document
Medical Text Search
micromonovision IOL implantation intraocular lens
Medical Text Search
monovision cataract surgery target refraction presbyopia IOL
GradeResponse
GradeResponse
Medical Text Search
micromonovision mini monovision target refraction -0.5 diopter blended vision
Medical Text Search
Kanski Zia Clinical Ophthalmology IOL monovision presbyopia cataract
Here is a comprehensive answer on achieving micromonovision by IOL implantation, drawing from the retrieved references and supplemented with established clinical knowledge from Kanski & Zia's Clinical Ophthalmology:
Micromonovision by IOL Implantation
Concept and Rationale
Monovision involves intentionally targeting one eye for distance and the fellow eye for near or intermediate vision after IOL implantation, exploiting interocular blur suppression — the brain's ability to suppress the defocused image from one eye without significant visual degradation (Cataracts in the Adult Eye, p. 29).
Micromonovision (also called modified monovision or mini-monovision) is a refinement that uses a smaller anisometropic target — typically −0.50 to −0.75 D in the non-dominant eye — rather than the conventional monovision target of −1.75 D or more. This preserves better binocular function at the cost of somewhat reduced near vision.
Target Refraction Strategy
| Type | Dominant Eye (Distance) | Non-dominant Eye (Near/Intermediate) |
|---|---|---|
| Conventional monovision | Plano (0.00 D) | −1.75 D or more |
| Micromonovision / Modified monovision | Plano (0.00 D) | −0.50 to −0.75 D |
| Blended vision | Plano (0.00 D) | −1.25 to −1.50 D |
According to Cataracts in the Adult Eye (p. 29), modified monovision (anisometropia of ~−0.75 D) preserves binocular contrast sensitivity and stereopsis significantly better than conventional monovision, though near vision is comparatively reduced.
IOL Selection for Micromonovision
1. Monofocal IOLs
- The standard approach: implant a monofocal IOL targeted to plano in the dominant eye and select an IOL power that achieves −0.50 to −0.75 D in the non-dominant eye.
- IOL power calculations use standard biometry (optical coherence biometry preferred), and target refraction is adjusted accordingly using the IOL power formula (Barrett Universal II, Haigis, Holladay 2).
- Small adjustments in IOL power (typically 0.5 D steps) allow fine-tuning of the near target.
2. Monofocal vs. Multifocal in Monovision Context
- A comparison study found no statistically significant difference in bilateral uncorrected distance/near vision or satisfaction scores between bilateral multifocal IOLs and bilateral monofocal IOLs with monovision (Cataracts in the Adult Eye, p. 29).
- Micromonovision with monofocal IOLs avoids halos, glare, and contrast sensitivity loss associated with diffractive multifocal IOLs — an important patient quality-of-life consideration.
3. Extended Depth of Focus (EDOF) IOLs
- EDOF IOLs (e.g., Tecnis Symfony) in the non-dominant eye with plano target in the dominant eye represent a modern micromonovision variant: the EDOF provides intermediate and some near vision while preserving contrast sensitivity better than multifocals.
Practical Steps for IOL-Based Micromonovision
- Determine ocular dominance — dominant eye is corrected for distance (target: plano or +0.00 to −0.25 D). Non-dominant eye receives the myopic target.
- Preoperative trial — if feasible, trial monovision with contact lenses or trial frames preoperatively to confirm patient tolerance and assess suppression ability.
- Biometry and IOL power calculation — use modern optical biometry (IOLMaster, Lenstar) with an accurate formula; select the IOL power 1–2 steps stronger (higher power) than what would achieve emmetropia in the non-dominant eye to land at ~−0.50 to −0.75 D.
- Patient counseling — patients should understand:
- Some compromise in stereoacuity and binocular contrast sensitivity
- Driving at night may require spectacle correction
- Adaptation period of 4–8 weeks is normal
- Sequence — operate on the dominant (distance) eye first; assess achieved refraction before planning the non-dominant (near) eye's IOL power.
Patient Selection (Kanski & Zia)
Good candidates:
- Prior successful monovision contact lens wearers
- Patients with realistic expectations regarding near spectacle independence
- Those who prioritize intermediate vision (computer work)
Poor candidates (Cataracts in the Adult Eye, p. 29):
- Latent strabismus
- Macular disease
- Optic nerve disease
- High demand for fine stereopsis (e.g., surgeons, pilots)
Outcomes
- Overall monovision acceptance rate ~90% when dominant eye is corrected for distance (Cataracts in the Adult Eye, p. 29)
- Micromonovision (−0.75 D) offers better binocular quality of vision (contrast sensitivity, stereopsis) than conventional monovision
- Near vision is a trade-off — intermediate distances (60–80 cm) are more reliably covered than close near (33–40 cm)
- Patients with prior successful optical monovision are particularly well-suited and have the highest satisfaction rates
Summary
Micromonovision via IOL implantation targets the dominant eye to plano and the non-dominant eye to a mild myopic refraction of −0.50 to −0.75 D using a standard monofocal (or EDOF) IOL, guided by accurate biometry and IOL power selection. It represents an optimal balance between spectacle independence and preserved binocular function — delivering better stereopsis and contrast sensitivity than full monovision while still reducing dependence on near correction for intermediate tasks.
This is a shared conversation. Sign in to Orris to start your own chat.